SCHEMBL13694459

SCHEMBL13694459

O=NC1CCCCO1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6658223 0.78
SCHEMBL29168738 0.77
SCHEMBL2459378 0.74
SCHEMBL1779496 0.73
SCHEMBL1681850 0.69 NOS2 (0.33)
SCHEMBL14106695 0.69
SCHEMBL10931805 0.69
SCHEMBL13989172 0.69
SCHEMBL4454838 0.69
SCHEMBL12274071 0.65

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2019074562-A1 PRODUCTION OF 1,5-PENTANEDIOL VIA UPGRADING OF TETRAHYDROFURFURYL ALCOHOL WISCONSIN ALUMNI RESEARCH FOUNDATION (US) 2019-04-18 WO disclosed
US-20150370104-A1 LIQUID CRYSTAL DISPLAY PANEL AND METHOD FOR PREPARING THE SAME, AND DISPLAY DEVICE BOE TECHNOLOGY GROUP CO., LTD. (CN) 2015-12-24 US disclosed
EP-2763949-A1 GERANYLGERANYLACETONE DERIVATIVES Coyote Pharmaceuticals, Inc. (US) 2014-08-13 EP disclosed
WO-2013052148-A1 GERANYLGERANYLACETONE DERIVATIVES COYOTE PHARMACEUTICALS, INC. (US) 2013-04-11 WO disclosed
US-20130085283-A1 GERANYLGERANYLACETONE DERIVATIVES COYOTE PHARMACEUTICALS, INC. 2013-04-04 US disclosed
US-20090221433-A1 SMALL MOLECULE PRINTING NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2009-09-03 US disclosed